Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Vondrakova

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Leukemia Research|August 14, 2013
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromesJaroslav Cermak, Anna Jonasova, Jana Vondrakova, et al.
Case Reports in Hematology|September 1, 2012
Treatment of chronic myelomonocytic leukemia with 5-azacytidine: case reportsPeter Rohon, Jana Vondrakova, Anna Jonasova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 23, 2009
Saliva as a diagnostic mediumRichard Pink, Jiri Simek, Jana Vondrakova, et al.
Hemoglobin|May 24, 2011
Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndromeJaroslav Cermak, Anna Jonasova, Jana Vondrakova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 9, 2010
Salivary neutrophils level as an indicator of bone marrow engraftmentRichard Pink, Jana Vondrakova, Peter Tvrdy, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 15, 2009
Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantationVit Prochazka, Edgar Faber, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 17, 2008
Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancyIvana Skoumalova, Jana Vondrakova, Peter Rohon, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 9, 2011
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantationVit Prochazka, Edgar Faber, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 24, 2009
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionTomas Papajik, Zuzana Pikalova, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 17, 2012
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemiaLudek Raida, Pavel Tucek, Edgar Faber, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Leukemia Research|August 14, 2013
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromesJaroslav Cermak, Anna Jonasova, Jana Vondrakova, et al.
Case Reports in Hematology|September 1, 2012
Treatment of chronic myelomonocytic leukemia with 5-azacytidine: case reportsPeter Rohon, Jana Vondrakova, Anna Jonasova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 23, 2009
Saliva as a diagnostic mediumRichard Pink, Jiri Simek, Jana Vondrakova, et al.
Hemoglobin|May 24, 2011
Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndromeJaroslav Cermak, Anna Jonasova, Jana Vondrakova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|March 9, 2010
Salivary neutrophils level as an indicator of bone marrow engraftmentRichard Pink, Jana Vondrakova, Peter Tvrdy, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 15, 2009
Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantationVit Prochazka, Edgar Faber, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 17, 2008
Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancyIvana Skoumalova, Jana Vondrakova, Peter Rohon, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 9, 2011
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantationVit Prochazka, Edgar Faber, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 24, 2009
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionTomas Papajik, Zuzana Pikalova, Ludek Raida, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 17, 2012
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemiaLudek Raida, Pavel Tucek, Edgar Faber, et al.
Pageof 2